Purdue , Johnson & Johnson and Johnson & Johnson have lost a bid to delay a multi- multibillion-dollar trial in which they will be accused of helping to fuel an abuse and overdose epidemic in Purdue . OxyContin maker Purdue Pharma LP and two other drugmakers on Friday lost a bid to delay a landmark trial set for May in a multibillion-dollar lawsuit by Oklahoma’s attorney general accusing them of helping fuel an opioid abuse and overdose epidemic in the state. Oklahoma is now believed to be considering filing for Chapter 11 bankruptcy protection to halt the case. Official reports have said opioids were involved in 47,600 deaths in 2017 . State and local government lawsuits accuse Purdue and others of downplaying drug risks through deceptive marketing. The Oklahoma trial is set for May. The firms deny wrongdoing and say the products carry warning labels.
Purdue , Johnson & Johnson and Johnson & Johnson have lost a bid to delay a multi- multibillion-dollar trial in which they will be accused of helping to fuel an abuse and overdose epidemic in Purdue . Oklahoma is now believed to be considering filing for Chapter 11 bankruptcy protection to halt the case. Official reports have said opioids were involved in 47,600 deaths in 2017 . State and local government lawsuits accuse Purdue and others of downplaying drug risks through deceptive marketing. The Oklahoma trial is set for May. The firms deny wrongdoing and say the products carry warning labels.